European Commission Urged To Fix EU Law Before Addressing IPR Protections In Third Countries

European Commission image

Efforts to revamp protection for and enforcement of intellectual property rights in non-EU countries are welcome, but the European Commission should get Europe’s IPR house in order first, a new draft report by the European Parliament International Trade (INTA) Committee says. Meanwhile, internal IPR reform is advancing on several fronts, said the EC, which gave Intellectual Property Watch an update on the various measures.

At WIPO, Experts Look At Challenges, Solutions For Successful Tech Transfer

tech transfer 1

Low levels of research and development in developing countries, human capital deficit and construction of balanced intellectual property systems were at the centre of discussions at the recent Expert Forum on Technology Transfer at the World Intellectual Property Organization.

USPTO Acting Director Discusses Patent Quality, Pendency, Harmonisation

trilateral-IP-offices-logo-square

At today’s meeting of the “trilateral offices” – the United States, Europe and Japan – Deputy Director of the US Patent and Trademark Office Michelle Lee gave an update of USPTO activities, including improvements in patent quality, patent pendency, and discussions about patent harmonisation.

EPO Hits New Record In Patent Filings; US, China Rise

EPO President Benoît Battistelli

BRUSSELS – In 2014, patent filings at the European Patent Office (EPO) reached an all-time high, as announced by EPO President Benoît Battistelli last week at the traditional Annual Results Press Conference. Among key patenting trends were figures revealing strong growth in filings from the United States and China.

Design Law Seminar In Geneva Discusses Current Issues And Concerns

design image

Experts gathered in Geneva recently to discuss current issues and future developments in the protection of industrial designs and its importance, and give practical advice on suitable ways to protect and enforce the design rights.

Why The Request By Least Developed Countries For An Extension Of The Transitional Period For Granting And Enforcing Medicines Patents Needs To Be Supported

Ellen 't Hoen

Ellen ‘t Hoen writes: On 24 February 2015 Bangladesh on behalf of the 34 Least Developed Country members (LDCs) of the World Trade Organization (WTO) submitted a request for an extension of the transitional period under article 66.1 TRIPS with respect to pharmaceutical products until the country is no longer classified as LDC.[1] The original extension, set to expire on 1st January 2016, specifically removes the obligation for LDCs to comply with Section 5 (Patents) and Section 7 (Protection of Undisclosed Information) of Part II of TRIPS, including any obligation to enforce rights under these provisions.

It is a little known fact that since the adoption of the 2001 Doha Declaration on TRIPS and Public Health, LDCs have frequently used the extension in day-to-day procurement of low cost generic medicines, in particular to access medicines needed for the treatment of HIV.

South Africa Awaits Patent Reforms With Hope, Concern

Fix the Patent Laws image

CAPE TOWN – South Africa’s new policy on patents could go to the Cabinet for approval soon, says Doctors without Borders (Médecins Sans Frontières, MSF), one of the organisations spearheading the Fix the Patent Laws campaign in the country.

New Quiet Initiative To Improve Drug Access In Middle-Income Countries, Change Country Classification System

developing country crowd image

This week a confidential high-level expert meeting was convened in Geneva to start work on a potential change in the country classification used by global health actors to remedy the growing problem of access to medicines in middle-income countries.

In 21st Century No One Should Die For Lack Of Access To Medicines, Participants At UN Forum Say

Price of Medicines

Last week’s 2015 Social Forum led by the UN Office of the High Commissioner for Human Rights (OHCHR) called for urgent action to facilitate access to medicines. In particular, the functioning of the intellectual property system was put into question. A number of recommendations were drawn by the secretariat after having been identified by participants.

TRIPS In Question During Social Forum Discussion On Access To Medicines

ohchr logo 2

Intellectual property rights are hindering access to medicines by maintaining monopolies and high prices, according to speakers at an annual United Nations forum on human rights last week. Flexibilities enshrined in the World Trade Organization intellectual property agreement are hampered by political and economical pressure, they said, and a new system should be devised for pharmaceutical products.